Drug kinetics and drug resistance in optimal chemotherapy
- PMID: 7881194
- DOI: 10.1016/0025-5564(94)00027-w
Drug kinetics and drug resistance in optimal chemotherapy
Abstract
A system of differential equations for the control of tumor cells growth in a cycle nonspecific chemotherapy is presented. First-order drug kinetics and drug resistance are taken into account in a class of optimal control problems. The results show that the strategy corresponding to the maximum rate of drug injection is optimal for the Malthusian model of cell growth (which is a relatively good model for the initial phase of tumor growth). For more general models of cell growth, this strategy proved to be suboptimal under certain conditions.
Similar articles
-
Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.Math Biosci. 1995 Feb;125(2):211-28. doi: 10.1016/0025-5564(94)00028-x. Math Biosci. 1995. PMID: 7881195
-
Conflicting objectives in chemotherapy with drug resistance.Bull Math Biol. 1997 Jul;59(4):707-24. doi: 10.1007/BF02458426. Bull Math Biol. 1997. PMID: 9214850
-
Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.IMA J Math Appl Med Biol. 1994;11(1):45-59. doi: 10.1093/imammb/11.1.45. IMA J Math Appl Med Biol. 1994. PMID: 8057040
-
Role of optimal control theory in cancer chemotherapy.Math Biosci. 1990 Oct;101(2):237-84. doi: 10.1016/0025-5564(90)90021-p. Math Biosci. 1990. PMID: 2134485 Review.
-
Combination chemotherapy--theory and practice.Semin Oncol. 1977 Jun;4(2):227-53. Semin Oncol. 1977. PMID: 327555 Review. No abstract available.
Cited by
-
Evolution of acquired resistance to anti-cancer therapy.J Theor Biol. 2014 Aug 21;355:10-20. doi: 10.1016/j.jtbi.2014.02.025. Epub 2014 Mar 25. J Theor Biol. 2014. PMID: 24681298 Free PMC article. Review.
-
Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.PLoS Comput Biol. 2009 Nov;5(11):e1000557. doi: 10.1371/journal.pcbi.1000557. Epub 2009 Nov 6. PLoS Comput Biol. 2009. PMID: 19893626 Free PMC article.
-
Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients.PLoS One. 2015 Nov 4;10(11):e0141665. doi: 10.1371/journal.pone.0141665. eCollection 2015. PLoS One. 2015. PMID: 26536620 Free PMC article.
-
Tackling the problems of tumour chemotherapy by optimal drug scheduling.J Clin Diagn Res. 2013 Jul;7(7):1404-7. doi: 10.7860/JCDR/2013/6223.3144. Epub 2013 May 31. J Clin Diagn Res. 2013. PMID: 23998076 Free PMC article.
-
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient.PLoS Biol. 2017 Feb 9;15(2):e2001110. doi: 10.1371/journal.pbio.2001110. eCollection 2017 Feb. PLoS Biol. 2017. PMID: 28182734 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources